High-technology platforms recently introduced in genetic analysis, such as biochips or microarrays, and the Gendiag’s professional experience in R&D and management, have enabled us to reach the project objectives started in 2006:  Six products applied in the field of personalized medicine have been developed by Gendiag in this period.